Map pin300 Rue Ellice, Beauharnois, QC, J6N 1X3, CA

Multiresidential Redevelopment Opportunity - 300 Ellice Street

Multiresidential Redevelopment Opportunity - 300 Ellice Street_Actifs en vente

Caractéristiques de l'actif

Surface de l'actif Net
2 499 m²
Taille du terrain Brut
5 268 m²

Description

JLL's Quebec Capital Markets Team is pleased to present for sale 300 Ellice Street in Beauharnois. This commercial property presents exceptional multifamily redevelopment potential, featuring a ±26,900 SF building situated on a ±56,700 SF lot.. Located in an area undergoing major revitalization, the site offers versatile zoning that permits various uses including office, services, commerce, lodging, restaurant, and multi-family housing up to 5 floors. The property's strategic location in Beauharnois, part of the Greater Montreal Area with a growing population, coupled with its redevelopment potential, makes it a remarkable investment opportunity.

...

Points clés d'investissement

• Property features ±26,900 SF building on a ±56,700 SF lot

• Redevelopment opportunity with zoning in place allowing for a 5-floor project

• Versatile zoning permits various uses including office, services, commerce, lodging, restaurant, and multi-family housing

• Located in an area undergoing major revitalization, ideal for new development

• Situated in Beauharnois, part of the Greater Montreal Area, with a growing population

Multiresidential Redevelopment Opportunity - 300 Ellice Street 4_Actifs en vente
Multiresidential Redevelopment Opportunity - 300 Ellice Street 4_Actifs en vente
Multiresidential Redevelopment Opportunity - 300 Ellice Street (0 actifs)

Contacter l'équipe

Actifs similaires

Voir plusChevron Right
Vous avez des questions ? Consultez notre page FAQ
Voir la page FAQArrow Right

Financement JLL

Nous nous associons aux investisseurs pour structurer un financement plus intelligent et optimiser la performance de leur portefeuille. Contactez notre équipe pour découvrir une meilleure voie à suivre.
Dernière mise à jour Nov 11, 2025